tradingkey.logo

Elanco Animal Health Inc

ELAN

14.040USD

+0.250+1.81%
取引時間 ET15分遅れの株価
6.97B時価総額
18.69直近12ヶ月PER

Elanco Animal Health Inc

14.040

+0.250+1.81%
詳細情報 Elanco Animal Health Inc 企業名
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
企業情報
企業コードELAN
会社名Elanco Animal Health Inc
上場日Sep 20, 2018
最高経営責任者「CEO」Mr. Jeffrey N. (Jeff) Simmons
従業員数9000
証券種類Ordinary Share
決算期末Sep 20
本社所在地2500 Innovation Way N
都市GREENFIELD
証券取引所NYSE Consolidated
United States of America
郵便番号46140-9163
電話番号18773526261
ウェブサイトhttps://www.elanco.com/
企業コードELAN
上場日Sep 20, 2018
最高経営責任者「CEO」Mr. Jeffrey N. (Jeff) Simmons
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
150.03K
+26.80%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
99.26K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
80.96K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
79.40K
--
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
74.50K
--
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
62.55K
-1.82%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
53.92K
+100.82%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
150.03K
+26.80%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
99.26K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
80.96K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Pet Health
635.00M
53.23%
Farm Animal
546.00M
45.77%
Contract Manufacturing
12.00M
1.01%
地域別USD
会社名
収益
比率
International
639.00M
53.56%
United States
554.00M
46.44%
事業別
地域別
事業別USD
会社名
収益
比率
Pet Health
635.00M
53.23%
Farm Animal
546.00M
45.77%
Contract Manufacturing
12.00M
1.01%
株主
更新時刻: Fri, May 16
更新時刻: Fri, May 16
株主統計
種類
株主統計
株主統計
比率
Dodge & Cox
16.70%
PRIMECAP Management Company
10.11%
The Vanguard Group, Inc.
9.69%
Fidelity Management & Research Company LLC
7.71%
Black Creek Investment Management, Inc.
4.44%
Other
51.35%
株主統計
株主統計
比率
Dodge & Cox
16.70%
PRIMECAP Management Company
10.11%
The Vanguard Group, Inc.
9.69%
Fidelity Management & Research Company LLC
7.71%
Black Creek Investment Management, Inc.
4.44%
Other
51.35%
種類
株主統計
比率
Investment Advisor
63.16%
Investment Advisor/Hedge Fund
32.92%
Hedge Fund
3.35%
Individual Investor
1.08%
Research Firm
1.01%
Sovereign Wealth Fund
0.79%
Pension Fund
0.77%
Bank and Trust
0.44%
Family Office
0.11%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
879
514.22M
103.54%
-39.32M
2025Q1
974
511.32M
102.96%
-71.50M
2024Q4
996
503.77M
101.85%
-80.73M
2024Q3
1000
494.48M
100.04%
-96.31M
2024Q2
1034
494.94M
100.16%
-92.98M
2024Q1
1051
494.01M
100.22%
-99.13M
2023Q4
1048
492.96M
100.04%
-103.67M
2023Q3
1055
493.54M
100.18%
-93.98M
2023Q2
1067
490.17M
99.54%
-75.35M
2023Q1
1071
498.03M
101.25%
-46.19M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Dodge & Cox
82.92M
16.7%
-260.08K
-0.31%
Mar 31, 2025
PRIMECAP Management Company
50.22M
10.11%
-941.63K
-1.84%
Mar 31, 2025
The Vanguard Group, Inc.
48.14M
9.69%
-437.73K
-0.90%
Mar 31, 2025
Fidelity Management & Research Company LLC
38.30M
7.71%
+9.79M
+34.35%
Mar 31, 2025
Black Creek Investment Management, Inc.
22.04M
4.44%
+1.61M
+7.87%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
20.46M
4.12%
+2.56M
+14.32%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.06M
4.04%
-618.85K
-2.99%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
15.98M
3.22%
+292.65K
+1.87%
Mar 31, 2025
Fidelity Institutional Asset Management
15.55M
3.13%
+3.83M
+32.70%
Mar 31, 2025
Shapiro Capital Management LLC
12.33M
2.48%
-24.38K
-0.20%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
SPDR S&P Pharmaceuticals ETF
3.83%
iShares U.S. Pharmaceuticals ETF
3.57%
First Trust Health Care Alphadex Fund
3.03%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.72%
First Trust NASDAQ Pharmaceuticals ETF
2.36%
Brandes US Small-Mid Cap Value ETF
2.14%
VanEck Agribusiness ETF
1.51%
First Trust Mid Cap Value AlphaDEX Fund
0.98%
Global X Adaptive US Factor ETF
0.72%
Federated Hermes MDT Large Cap Value ETF
0.7%
詳細を見る
SPDR S&P Pharmaceuticals ETF
比率3.83%
iShares U.S. Pharmaceuticals ETF
比率3.57%
First Trust Health Care Alphadex Fund
比率3.03%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率2.72%
First Trust NASDAQ Pharmaceuticals ETF
比率2.36%
Brandes US Small-Mid Cap Value ETF
比率2.14%
VanEck Agribusiness ETF
比率1.51%
First Trust Mid Cap Value AlphaDEX Fund
比率0.98%
Global X Adaptive US Factor ETF
比率0.72%
Federated Hermes MDT Large Cap Value ETF
比率0.7%
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
tradingkey.logo
tradingkey.logo
当社が提供する日中データはRefinitivより配信されており、同社の利用規約が適用されます。終値データ(過去・現在)についてもRefinitivより提供されています。全ての相場情報は現地取引所時間で表示されます。米国株式のリアルタイム最終取引価格はNasdaqを通じて報告された取引のみを反映しています。日中データは最低15分遅れ、または各取引所の要件に準じて遅延配信されます。
* 当コンテンツ(分析資料・取引戦略等)は第三者プロバイダーであるTrading Centralより提供されており、記載の見解は分析官の独立した評価及び判断に基づくものです。投資家個々の投資目的や財務状況は考慮されておりません。
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。
KeyAI